Philadelphia Corporation for Aging

Philadelphia Corporation for Aging (PCA)


This class/collective action lawsuit was filed in November 2022 and is going forward in the federal court in Philadelphia. The lawsuit seeks to recover unpaid overtime wages for OAPS Investigators employed by Philadelphia Corporation for Aging ("PCA"). The lawsuit alleges that PCA violated Pennsylvania and federal wage laws by failing to pay Investigators extra overtime wages for hours worked over 40 per week. PCA is expected to deny liability and assert that Investigators are not legally entitled to overtime wages. The judge has not yet decided who will win this case.

Individuals who worked as OAPS Investigators anytime within the past three years can join the lawsuit by completing and returning the "Consent to Join" form available below. However, if you are interested in joining the lawsuit, we recommend that you call the office at (215) 866-1551 so we can confirm your eligibility to join.

You can learn more about the lawsuit below. If you would like additional information, please call our office at (215) 866-1551.

Case Updates

NOV 18, 2022

Today, we started this lawsuit by filing a Complaint in the federal court in Philadelphia. A copy of the Complaint is available below.

NOV 28, 2022

Today, two former PCA Investigators joined the lawsuit by completing a "Consent to Join" form.

Case Documents

  • “Have significant experience in similar matters under the [Pennsylvania Minimum Wage Act]” - Torres v. Brandsafway Indus. LLC, 2023 U.S. Dist. LEXIS 10631, at *8 (W.D. Pa. Jan. 20, 2023).
  • “I highly recommend this law firm.” - Brandon
  • “I highly recommend contacting them to discuss your case.” - Tanya

    Contact Our Firm

    Fill Out the Form Below to Get Started

    • Please enter your first name.
    • Please enter your last name.
    • Please enter your phone number.
      This isn't a valid phone number.
    • Please enter your email address.
      This isn't a valid email address.
    • Please make a selection.
    • Please enter a message.